Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients

OBJECTIVE: It is important to analyze and track Epidermal Growth Factor Receptor (EGFR) mutation status for predicting efficacy and monitoring resistance throughout EGFR-tyrosine kinase inhibitors (TKIs) treatment in non-small cell lung cancer (NSCLC) patients. The objective of this study was to det...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li, Xuefei, Ren, Ruixin, Ren, Shengxiang, Chen, Xiaoxia, Cai, Weijing, Zhou, Fei, Zhang, Yishi, Su, Chunxia, Zhao, Chao, Li, Jiayu, Cheng, Ningning, Zhao, Mingchuan, Zhou, Caicun
Formato: Artigo
Lenguaje:Inglês
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145390/
https://ncbi.nlm.nih.gov/pubmed/25180058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.04.006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares